Please click here to obtain permission to reproduce this image.
Click on image to view larger version.
Figure 4 RANTES Levels in Blood Pre- and Post–Lipid-Lowering Therapy
(A) Plasma regulated on activation normally T-cell expressed and secreted (RANTES) concentration at baseline and after 4 weeks of lipid-lowering therapy with atorvastatin (open bars, n = 25) or a combination of ezetimibe plus atorvastatin (solid bars, n = 26). (B) Differences ( c) in plasma RANTES concentration (level after 4 weeks of lipid-lowering therapy minus level before changing treatment). c = concentration.
|
